Girl, n = 265 | 95% CI | Boy (Int) n = 133 | 95% CI | Boy (Control), n = 131 | 95% CI | |
---|---|---|---|---|---|---|

TdaP | ||||||

Needed, n (%) | 236 (89) | 124 (93) | 121 (92) | |||

Of those who needed, consented at registration, n (%) | 183 (78) | 72%–83% | 87 (70) | 61%–78% | 84 (69) | 61%–78% |

Of those who needed, received vaccine, n (%) | 160 (68) | 61%–74% | 78 (63) | 54%–71% | 45 (37) | 29%–46% |

MCV4 | ||||||

Needed, n (%) | 248 (94) | 133 (100) | 130 (99) | |||

Of those who needed, consented at registration, n (%) | 172 (69) | 63%–75% | 88 (66) | 57%–74% | 88 (68) | 59%–76% |

Of those who needed, received vaccine, n (%) | 142 (57) | 51%–64% | 80 (60) | 51%–69% | 49 (38) | 29%–47% |

HPV#1 | ||||||

Needed, n (%) | 253 (95) | — | — | |||

Of those who needed, consented at registration, n (%) | 158 (62) | 56%–68% | — | — | ||

Of those who needed, received vaccine, n (%) | 149 (59) | 53%–65% | — | — |

Int, intervention.